Journal articles
Pett SL;  Amin J;  Horban A;  Andrade-Villanueva J;  Losso M;  Porteiro N;  Madero JS;  Belloso W;  Tu E;  Silk D;  Kelleher A;  Harrigan R;  Clark A;  Sugiura W;  Wolff M;  Gill J;  Gatell J;  Clarke A;  Ruxrungtham K;  Prazuck T;  Kaiser R;  Woolley I;  Alberto Arnaiz J;  Cooper D;  Rockstroh JK;  Mallon P;  Emery S;  Fisher M;  Rockstroh J;  Stellbrink J;  Merlin K;  Yeung J;  Fsadni B;  Marks K;  Suzuki K;  Rismanto N;  Salomon H;  Rubio AE;  Chibo D;  Birch C;  Swenson L;  Chan D;  Berg T;  Obermeier M;  Schuelter E;  Aragon SS;  Luebke N;  Coughlan S;  Dean J;  Iwatani Y;  Teran GR;  Avila S;  Sirivichayakul S;  Naphassanant M;  Ubolyam S;  Kaye S;  Land S;  Walker S;  Haubrich R;  DeJesus E;  Berthon-Jones N;  Espinosa N;  Courtney-Vega K;  Absar N;  Haskelberg H;  Robson R;  Donaldson A;  Guelman D;  Gambardella L;  Valdovinos M;  Arnaiz J;  Beleta H;  Ramos N;  Targa M;  Späth B;  Boesecke C;  Engelhardt A;  Perry N;  Beckthold B;  Drummond F;  Lefevre E;  Corr S;  Grant C;  Lupo S;  Peroni L;  Sanchez M;  De Paz Sierra M;  Viloria G;  Parlante A;  Bissio E;  Luchetti P;  Confalonieri V;  Warley E;  Vieni I;  Vilas C;  Zarate A;  Mayer G;  Elliot J;  Hagenauer M;  Kelley M;  Bloch M;  Cooper D, 2018, 'Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study', HIV Medicine, 19,  pp. 65 - 71, http://dx.doi.org/10.1111/hiv.12532
Cook L;  Munier CML;  Seddiki N;  van Bockel D;  Ontiveros N;  Hardy MY;  Gillies JK;  Levings MK;  Reid HH;  Petersen J;  Rossjohn J;  Anderson RP;  Zaunders JJ;  Tye-Din JA;  Kelleher AD, 2017, 'Circulating gluten-specific FOXP3+CD39+ regulatory T cells have impaired suppressive function in patients with celiac disease', Journal of Allergy and Clinical Immunology, 140,  pp. 1592 - 1603.e8, http://dx.doi.org/10.1016/j.jaci.2017.02.015
Murray DD;  Suzuki K;  Law M;  Trebicka J;  Neuhaus Nordwall J;  Johnson M;  Vjecha MJ;  Kelleher AD;  Emery S;  Han A, 2017, 'Circulating MIR-122 and MIR-200a as biomarkers for fatal liver disease in ART-treated, HIV-1-infected individuals', Scientific Reports, 7,  pp. 10934, http://dx.doi.org/10.1038/s41598-017-11405-8
McLaren PJ;  Pulit SL;  Gurdasani D;  Bartha I;  Shea PR;  Pomilla C;  Gupta N;  Gkrania-Klotsas E;  Young EH;  Bannert N;  Del Amo J;  Gill MJ;  Gilmour J;  Kellam P;  Kelleher AD;  Sönnerborg A;  Zangerle R;  Post FA;  Fisher M;  Haas DW;  Walker BD;  Porter K;  Goldstein DB;  Sandhu MS;  De Bakker PIW;  Fellay J, 2017, 'Evaluating the impact of functional genetic variation on HIV-1 Control', Journal of Infectious Diseases, 216,  pp. 1063 - 1069, http://dx.doi.org/10.1093/infdis/jix470
Murray JM;  Zaunders J;  Emery S;  Cooper DA;  Hey-Nguyen WJ;  Koelsch KK;  Kelleher AD, 2017, 'HIV dynamics linked to memory CD4+ T cell homeostasis', Plos One, 12,  pp. e0186101, http://dx.doi.org/10.1371/journal.pone.0186101
Smoleń-Dzirba J;  Rosińska M;  Janiec J;  Beniowski M;  Cycoń M;  Bratosiewicz-Wąsik J;  Wasik TJ;  Kelleher T;  Cooper D;  Grey P;  Finlayson R;  Bloch M;  Ramacciotti T;  Gelgor L;  Smith D;  Zangerle R;  Gill J;  Lutsar I;  Chêne G;  Dabis F;  Thiebaut R;  Masquelier B;  Costagliola D;  Guiguet M;  Vanhems P;  Chaix ML;  Ghosn J;  Meyer L;  Boufassa F;  Hamouda O;  Kücherer C;  Bartmeyer B;  Antoniadou A;  Chrysos G;  Daikos GL;  Touloumi G;  Pantazis N;  Katsarou O;  Rezza G;  Dorrucci M;  Monforte AD;  De Luca A;  Prins M;  Geskus R;  van der Helm J;  Schuitemaker H;  Sannes M;  Brubakk O;  Kran AMB;  Muga R;  Tor J;  de Olalla PG;  Cayla J;  del Amo J;  Moreno S;  Monge S;  del Romero J;  Pérez-Hoyos S;  Bucher HC;  Rickenbach M;  Francioli P;  Malyuta R;  Murphy G;  Sabin C;  Porter K;  Johnson A;  Phillips A;  Babiker A;  Pillay D;  Morrison C;  Salata R;  Mugerwa R;  Chipato T;  Amornkul PN;  Gilmour J;  Kamali A;  Karita E;  Burns F;  Giaquinto C;  Gibb D;  Grarup J;  Kirk O;  Kjaer J;  Panteleev A;  Reiss P;  Thorne C;  Aboulker JP;  Albert J;  Asandi S;  De Wit S;  De Wolf F;  Gatell J;  Karpov I;  Ledergerber B;  Lundgren J;  Møller C;  Rakhmanova A;  Rockstroh J;  Anne AV, 2017, 'HIV-1 infection in persons homozygous for CCR5-Δ32 allele: The next case and the review', AIDS Reviews, 19,  pp. 219 - 230
Nasr N;  Alshehri AA;  Wright TK;  Shahid M;  Heiner BM;  Harman AN;  Botting RA;  Helbig KJ;  Beard MR;  Suzuki K;  Kelleher AD;  Hertzog P;  Cunningham AL, 2017, 'Mechanism of interferon-stimulated gene induction in HIV-1- infected macrophages', Journal of Virology, 91, http://dx.doi.org/10.1128/JVI.00744-17
Madhavi V;  Wines BD;  Amin J;  Emery S;  Lopez E;  Kelleher A;  Center RJ;  Mark Hogarth P;  Chung AW;  Kent SJ;  Stratov I, 2017, 'HIV-1 Env- and Vpu-specific antibody-dependent cellular cytotoxicity responses associated with elite control of HIV', Journal of Virology, 91,  pp. 10.1128/jvi.00700 - 10.1128/jvi.00717, http://dx.doi.org/10.1128/JVI.00700-17
Phetsouphanh C;  Xu Y;  Munier ML;  Zaunders JJ;  Kelleher AD, 2017, 'Single-cell profiling of lineage determining transcription factors in antigen-specific CD4+ T cells reveals unexpected complexity in recall responses during immune reconstitution', Immunology and Cell Biology, 95,  pp. 640 - 646, http://dx.doi.org/10.1038/icb.2017.28
Madhavi V;  Kulkarni A;  Shete A;  Lee WS;  McLean MR;  Kristensen AB;  Ghate M;  Wines BD;  Hogarth PM;  Parsons MS;  Kelleher A;  Cooper DA;  Amin J;  Emery S;  Thakar M;  Kent SJ, 2017, 'Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts', Journal of Acquired Immune Deficiency Syndromes, 75,  pp. 345 - 353, http://dx.doi.org/10.1097/QAI.0000000000001380
Koelsch KK;  Rasmussen TA;  Hey-Nguyen WJ;  Pearson C;  Xu Y;  Bailey M;  Marks KH;  Sasson SC;  Taylor MS;  Tantau R;  Obeid S;  Milner B;  Morrissey O;  Pinto AN;  Suzuki K;  Busch MP;  Keating SM;  Kaiser P;  Yukl S;  Wong JK;  Hiener BM;  Palmer S;  Zaunders J;  Post JJ;  Chan DJ;  Avery S;  Milliken ST;  Kelleher AD;  Lewin SR;  Cooper DA;  Cooper D, 2017, 'Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals', Journal of Acquired Immune Deficiency Syndromes, 75,  pp. 328 - 337, http://dx.doi.org/10.1097/QAI.0000000000001381
Hey-Nguyen WJ;  Xu Y;  Pearson CF;  Bailey M;  Suzuki K;  Tantau R;  Obeid S;  Milner B;  Field A;  Carr A;  Bloch M;  Cooper DA;  Kelleher AD;  Zaunders JJ;  Koelsch KK, 2017, 'Quantification of Residual Germinal Center Activity and HIV-1 DNA and RNA Levels Using Fine Needle Biopsies of Lymph Nodes during Antiretroviral Therapy', AIDS Research and Human Retroviruses, 33,  pp. 648 - 657, http://dx.doi.org/10.1089/aid.2016.0171
Zaunders J;  Xu Y;  Kent SJ;  Koelsch KK;  Kelleher AD, 2017, 'Divergent expression of CXCR5 and CCR5 on CD4+ T cells and the paradoxical accumulation of T follicular helper cells during HIV infection', Frontiers in Immunology, 8,  pp. 495, http://dx.doi.org/10.3389/fimmu.2017.00495
Castley A;  Sawleshwarkar S;  Varma R;  Herring B;  Thapa K;  Dwyer D;  Chibo D;  Nguyen N;  Hawke K;  Ratcliff R;  Garsia R;  Kelleher A;  Nolan D, 2017, 'A national study of the molecular epidemiology of HIV-1 in', Plos One, 12,  pp. e0170601, http://dx.doi.org/10.1371/journal.pone.0170601
Kent SJ;  Kelleher AD, 2017, 'Expanding role for type i Interferons in restricting HIV growth', Immunology and Cell Biology, 95,  pp. 417 - 418, http://dx.doi.org/10.1038/icb.2017.15
Xu Y;  Phetsouphanh C;  Suzuki K;  Aggrawal A;  Graff-Dubois S;  Roche M;  Bailey M;  Alcantara S;  Cashin K;  Sivasubramaniam R;  Koelsch KK;  Autran B;  Harvey R;  Gorry PR;  Moris A;  Cooper DA;  Turville S;  Kent SJ;  Kelleher AD;  Zaunders J;  Aggarwal A, 2017, 'HIV-1 and SIV predominantly use CCR5 expressed on a precursor population to establish infection in T follicular helper cells', Frontiers in Immunology, 8,  pp. 376, http://dx.doi.org/10.3389/fimmu.2017.00376
Murray JM;  Maher S;  Mota T;  Suzuki K;  Kelleher AD;  Center RJ;  Purcell D, 2017, 'Differentiating founder and chronic HIV envelope sequences', Plos One, 12,  pp. e0171572, http://dx.doi.org/10.1371/journal.pone.0171572
Juno JA;  Bockel DV;  Kent SJ;  Kelleher AD;  Zaunders JJ;  Munier CML, 2017, 'Cytotoxic CD4 T cells-friend or foe during viral infection?', Frontiers in Immunology, 8, http://dx.doi.org/10.3389/fimmu.2017.00019
Zaunders J;  Howe A;  Ledger S;  Kelleher A;  Murray J;  Symonds G, 2017, '23 Knockdown of CCR5 expression in antigen-specific cytotoxic CD4 T cells', Journal of Virus Eradication, 3,  pp. 14 - 15, http://dx.doi.org/10.1016/s2055-6640(20)30728-7
Klemm V;  Mitchell J;  Cortez-Jugo C;  Cavalieri F;  Symonds G;  Caruso F;  Kelleher AD;  Ahlenstiel C, 2016, 'Achieving HIV-1 control through RNA-directed gene regulation', Genes, 7, http://dx.doi.org/10.3390/genes7120119
Keoshkerian E;  Hunter M;  Cameron B;  Nguyen N;  Sugden P;  Bull R;  Zekry A;  Maher L;  Seddiki N;  Zaunders J;  Kelleher A;  Lloyd AR;  Dolan K;  Haber P;  Rawlinson W;  Treloar C;  Dore G;  Luciani F, 2016, 'Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection', Journal of Viral Hepatitis, 23,  pp. 985 - 993, http://dx.doi.org/10.1111/jvh.12576
Tjiam MC;  Sariputra L;  Armitage JD;  Taylor JPA;  Kelleher AD;  Tan DBA;  Lee S;  Fernandez S;  French MA, 2016, 'Control of early HIV-1 infection associates with plasmacytoid dendritic cell-reactive opsonophagocytic IgG antibodies to HIV-1 p24', AIDS, 30,  pp. 2757 - 2765, http://dx.doi.org/10.1097/QAD.0000000000001242
Zaunders J;  Danta M;  Bailey M;  Mak G;  Marks K;  Seddiki N;  Xu Y;  Templeton DJ;  Cooper DA;  Boyd MA;  Kelleher AD;  Koelsch KK, 2016, 'CD4+ T follicular helper and IgA+ B cell numbers in gut biopsies from HIV-infected subjects on antiretroviral therapy are similar to HIV-uninfected individuals', Frontiers in Immunology, 7,  pp. 438, http://dx.doi.org/10.3389/fimmu.2016.00438
Munier CML;  van Bockel D;  Bailey M;  Ip S;  Xu Y;  Alcantara S;  Liu SM;  Denyer G;  Kaplan W;  Suzuki K;  Croft N;  Purcell A;  Tscharke D;  Cooper DA;  Kent SJ;  Zaunders JJ;  Kelleher AD, 2016, 'The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype', Vaccine, 34,  pp. 5251 - 5261, http://dx.doi.org/10.1016/j.vaccine.2016.09.009
Cook L;  Zaunders JJ;  Kelleher AD, 2016, 'Comment on "A cytokine- independent approach to identify antigen-specific human germinal center T follicular helper cells and rare antigen-specific CD41 T cells in blood', Journal of Immunology, 197,  pp. 2557 - 2558, http://dx.doi.org/10.4049/jimmunol.1601311
Mak G;  Zaunders JJ;  Bailey M;  Seddiki N;  Xu Y;  Cooper D;  Boyd M;  Kelleher A;  Danta M;  Koelsch KK, 2016, 'Gut integrity, CD4+T follicular helper cells, and IgA plus B cells in gastrointestinal-associated lymphoid tissue following ART', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 31,  pp. 6 - 6, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Pinkevych M;  Cromer D;  Tolstrup M;  Grimm AJ;  Cooper DA;  Lewin SR;  Søgaard OS;  Rasmussen TA;  Kent SJ;  Kelleher AD;  Davenport MP, 2016, 'Erratum: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV Remission (PLoS Pathogens (2015) 11:7 (e1005000) DOI: 10.1371/journal.ppat.1005000)', Plos Pathogens, 12,  pp. e1005745, http://dx.doi.org/10.1371/journal.ppat.1005745
Pinkevych M;  Kent SJ;  Tolstrup M;  Lewin SR;  Cooper DA;  Søgaard OS;  Rasmussen TA;  Kelleher AD;  Cromer D;  Davenport MP, 2016, 'Modeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5–8 Days', Plos Pathogens, 12,  pp. e1005740, http://dx.doi.org/10.1371/journal.ppat.1005740
Pett SL;  Amin J;  Horban A;  Andrade-Villanueva J;  Losso M;  Porteiro N;  Madero JS;  Belloso W;  Tu E;  Silk D;  Kelleher A;  Harrigan R;  Clark A;  Sugiura W;  Wolff M;  Gill J;  Gatell J;  Fisher M;  Clarke A;  Ruxrungtham K;  Prazuck T;  Kaiser R;  Woolley I;  Arnaiz JA;  Cooper D;  Rockstroh JK;  Mallon P;  Emery S;  Cooper D;  Tu E;  Silk D, 2016, 'Maraviroc, as a switch option, in HIV-1-infected individuals with stable, well-controlled HIV replication and R5-tropic virus on their first Nucleoside/Nucleotide reverse transcriptase inhibitor plus ritonavir-boosted protease inhibitor regimen: Week 48 Results of the randomized, multicenter March study', Clinical Infectious Diseases, 63,  pp. 122 - 132, http://dx.doi.org/10.1093/cid/ciw207
Li J;  Hardy K;  Phetsouphanh C;  Tu WJ;  Sutcliffe EL;  McCuaig R;  Sutton CR;  Zafar A;  Mee Ling Munier C;  Zaunders JJ;  Xu Y;  Theodoratos A;  Tan A;  SiewLim P;  Knaute T;  Masch A;  Zerweck J;  Brezar V;  Milburn PJ;  Dunn J;  Casarotto MG;  Turner SJ;  Seddiki N;  Kelleher AD;  Rao S;  Munier ML, 2016, 'Nuclear PKC-θ facilitates rapid transcriptional responses in human memory CD4+T cells through p65 and H2B phosphorylation', Journal of Cell Science, 129,  pp. 2448 - 2461, http://dx.doi.org/10.1242/jcs.181248
Pantazis N;  Touloumi G;  Meyer L;  Olson A;  Costagliola D;  Kelleher AD;  Lutsar I;  Chaix ML;  Fisher M;  Moreno S;  Porter K, 2016, 'The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment', AIDS, 30,  pp. 879 - 888, http://dx.doi.org/10.1097/QAD.0000000000000991
McAllery SA;  Ahlenstiel CL;  Suzuki K;  Symonds GP;  Kelleher AD;  Turville SG, 2016, 'The feasibility of incorporating Vpx into lentiviral gene therapy vectors', Molecular Therapy Methods and Clinical Development, 3,  pp. 16066, http://dx.doi.org/10.1038/mtm.2016.66
Appay V;  Kelleher AD, 2016, 'Immune activation and immune aging in HIV infection', Current Opinion in HIV and AIDS, 11,  pp. 242 - 249, http://dx.doi.org/10.1097/COH.0000000000000240
Zaunders J;  Jing J;  Leipold M;  Maecker H;  Kelleher AD;  Koch I, 2016, 'Computationally efficient multidimensional analysis of complex flow cytometry data using second order polynomial histograms', Cytometry Part A, 89,  pp. 44 - 58, http://dx.doi.org/10.1002/cyto.a.22704
, 2016, 'Oral abstracts of the 21st International AIDS Conference 18-22 July 2016, Durban, South Africa.', J Int AIDS Soc, 19,  pp. 21264, http://dx.doi.org/10.7448/IAS.19.6.21264
Pantazis N;  Touloumi G;  Meyer L;  Olson A;  Costagliola D;  Kelleher AD;  Lutsar I;  Chaix ML;  Fisher M;  Moreno S;  Porter K, 2015, 'The impact of transient cART in early HIV infection on viral suppression and immunologic response in later treatment', AIDS, http://dx.doi.org/10.1097/QAD.0000000000000991
Jarrin I;  Pantazis N;  Dalmau J;  Phillips AN;  Olson A;  Mussini C;  Boufassa F;  Costagliola D;  Porter K;  Blanco J;  Del Amo J;  Martinez-Picado J;  Chene G;  Sabin C;  Walker S;  Fisher M;  Kelleher T;  Cooper D;  Finlayson R;  Bloch M;  Ramacciotti T;  Gelgor L;  Smith D;  Zangerle R;  Gill J;  Lutsar I;  Dabis F;  Thiebaut R;  Guiguet M;  Vanhems P;  Chaix ML;  Ghosn J;  Meyer L;  Hamouda O;  Kucherer C;  Bartmeyer B;  Antoniadou A;  Chrysos G;  Daikos GL;  Touloumi G;  Katsarou O;  Rezza G;  Dorrucci M;  Monforte ADA;  De Luca A;  Prins M;  Geskus R;  Van Der Helm J;  Schuitemaker H;  Sannes M;  Brubakk O;  Kran AMB;  Rosinska M;  Muga R;  Tor J;  De Olalla PG;  Cayla J;  Moreno S;  Monge S;  Del Romero J;  Perez-Hoyos S;  Sonnerborg A;  Bucher HC;  Gunthard H;  Rickenbach M;  Malyuta R;  Murphy G;  Johnson A;  Babiker A;  Pillay D;  Morrison C;  Salata R;  Mugerwa R;  Chipato T;  Amornkul PN;  Gilmour J;  Kamali A;  Karita E;  Burns F;  Giaquinto C;  Grarup J;  Kirk O;  Bailey H;  Anne AV;  Panteleev A;  Thorne C;  Aboulker JP;  Albert J;  Asandi S;  De Wit S;  Reiss P;  Gatell J;  Karpov I;  Ledergerber B;  Lundgren J;  Møller C;  Rakhmanova A;  Rockstroh J;  Sandhu M;  Dedes N, 2015, 'Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4 + T-cell recovery once HIV-1 suppression is achieved?', AIDS, 29,  pp. 2323 - 2333, http://dx.doi.org/10.1097/QAD.0000000000000805
Murray DD;  Suzuki K;  Law M;  Trebicka J;  Neuhaus J;  Wentworth D;  Johnson M;  Vjecha MJ;  Kelleher AD;  Emery S;  Aagaard B;  Aragon E;  Arnaiz J;  Borup L;  Clotet B;  Dragsted U;  Fau A;  Gey D;  Grarup J;  Hengge U;  Herrero P;  Jansson P;  Jensen B;  Jensen K;  Juncher H;  Lopez P;  Lundgren JD;  Matthews C;  Mollerup D;  Pearson M;  Phillips A;  Reilev S;  Tillmann K;  Varea S;  Angus B;  Babiker A;  Cordwell B;  Darbyshire J;  Dodds W;  Fleck S;  Horton J;  Hudson F;  Moraes Y;  Pacciarini F;  Palfreeman A;  Paton N;  Smith N;  Van Hooff F;  Bebchuk J;  Collins G;  Denning E;  DuChene A;  Fosdick L;  Harrison M;  Herman-Lamin K;  Krum E;  Larson G;  Neaton J;  Nelson R;  Quan K;  Quan S;  Schultz T;  Thompson G;  Wyman N;  Carey C;  Chan F;  Cooper D;  Courtney-Rodgers D;  Drummond F;  Harrod M;  Jacoby S;  Kearney L;  Lin E;  Pett S;  Robson R;  Seneviratne N;  Stewart M;  Watts E;  Finley E;  Gordin F;  Sánchez A;  Standridge B;  Belloso W;  Davey R;  Duprez D;  Gatell J;  Hoy J;  Lifson A;  Pederson C;  Perez G;  Price R;  Prineas R;  Rhame F;  Sampson J;  Worley J;  Modlin J;  Beral V;  Chaisson R;  Fleming T;  Hill C;  Bloch M;  Cooper D;  Konecny P;  Carr A;  Medland N;  Sullivan J;  Han A, 2015, 'Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study', Plos One, 10,  pp. e0139981, http://dx.doi.org/10.1371/journal.pone.0139981
Hurst J;  Hoffmann M;  Pace M;  Williams JP;  Thornhill J;  Hamlyn E;  Meyerowitz J;  Willberg C;  Koelsch KK;  Robinson N;  Brown H;  Fisher M;  Kinloch S;  Cooper DA;  Schechter M;  Tambussi G;  Fidler S;  Babiker A;  Weber J;  Kelleher AD;  Phillips RE;  Frater J, 2015, 'Immunological biomarkers predict HIV-1 viral rebound after treatment interruption', Nature Communications, 6,  pp. 8495, http://dx.doi.org/10.1038/ncomms9495
Sasson SC;  McGill K;  Wienholt L;  Carr A;  Brown DA;  Kelleher AD;  Breit SN;  Sewell WA, 2015, 'Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay', Pathology, 47,  pp. 564 - 569, http://dx.doi.org/10.1097/PAT.0000000000000316
Ahlenstiel C;  Mendez C;  Lim STH;  Marks K;  Turville S;  Cooper DA;  Kelleher AD;  Suzuki K, 2015, 'Novel RNA duplex locks HIV-1 in a latent state via chromatin-mediated transcriptional silencing', Molecular Therapy Nucleic Acids, 4,  pp. e261, http://dx.doi.org/10.1038/mtna.2015.31
Lundgren JD;  Babiker AG;  Gordin F;  Emery S;  Grund B;  Sharma S;  Avihingsanon A;  Cooper DA;  Fätkenheuer G;  Llibre JM;  Molina JM;  Munderi P;  Schechter M;  Wood R;  Klingman KL;  Collins S;  Clifford Lane H;  Phillips AN;  Neaton JD;  Kelleher A;  Cysique L;  Jacoby S, 2015, 'Initiation of antiretroviral therapy in early asymptomatic HIV infection', New England Journal of Medicine, 373,  pp. 795 - 807, http://dx.doi.org/10.1056/NEJMoa1506816
Phetsouphanh C;  Zaunders JJ;  Kelleher AD, 2015, 'Detecting antigen-specific T cell responses: From bulk populations to single cells', International Journal of Molecular Sciences, 16,  pp. 18878 - 18893, http://dx.doi.org/10.3390/ijms160818878
Hoehn KB;  Gall A;  Bashford-Rogers R;  Fidler SJ;  Kaye S;  Weber JN;  McClure MO;  Kellam P;  Pybus OG;  Breckenridge A;  Clayden P;  Conlon C;  Conradie F;  Kaldor J;  Maggiolo F;  Ssali F;  Cooper DA;  Kaleebu P;  Ramjee G;  Schechter M;  Tambussi G;  Weber J;  Babiker A;  Peto T;  McLaren A;  Beral V;  Chene G;  Hakim J;  Porter K;  Thomason M;  Ewings F;  Gabriel M;  Johnson D;  Thompson K;  Cursley A;  Donegan K;  Fossey E;  Kelleher P;  Lee K;  Murphy B;  Nock D;  Phillips R;  Frater J;  Ohm Laursen L;  Robinson N;  Goulder P;  Brown H;  Bonsall D;  Erlwein O;  Helander A;  Robinson M;  Cook L;  Adcock G;  Ahmed P;  Paton N;  Kelleher A;  Moore R;  McFarlane R;  Roth N;  Finlayson R;  Tee BK;  Read T;  Kelly M;  Doong N;  Bloch M;  Workman C;  Grey P;  Cooper DA;  Lawr M;  Schechter M;  Gama P;  Mercon M;  Barbosa de Souza M;  Beppu Yoshida C;  Grangeiro da Silva JR;  Sampaio Amaral A;  Fernandes de Aguiar D;  de Fátima Melo M;  Quaresma Garrido R;  Tambussi G;  Nozza S;  Pogliaghi M;  Chiappetta S;  Della Torre L;  Gasparotto E;  D'Offizi G;  Vlassi C;  Corpolongo A;  Wood R;  Pitt J;  Orrell C;  Cilliers F;  Croxford R, 2015, 'Dynamics of immunoglobulin sequence diversity in HIV-1 infected individuals', Philosophical Transactions of the Royal Society B Biological Sciences, 370, http://dx.doi.org/10.1098/rstb.2014.0241
Amin J;  Becker S;  Belloso W;  Boffito M;  Cooper D;  Crabtree-Ramirez B;  Duncombe C;  Foulkes S;  Hill A;  Jessen H;  Kumar S;  Lee MP;  Nwizu C;  Read T;  Rooney J;  Schaffer K;  Shahar E;  Winston A;  Wolff M;  Young B;  Abela C;  Avihingsanon A;  Boyd M;  Carey D;  Clarke A;  Courtney-Vega K;  Delfino M;  Donaldson A;  Emery S;  Espinosa N;  Johannesen T;  Lin E;  Losso M;  Moricz A;  Pett S;  Phanupak P;  Puls R;  Pussadee K;  Sutheerasak P;  Tomlins L;  Ubolyam S;  bin Raja Azwa RIS;  Bissio E;  Calanni L;  Chetchotisakd P;  Doong N;  Elliott J;  Gazzard B;  Kelly M;  Laplume H;  del Carmen Luna N;  Lupo S;  Messina OG;  Mohapi L;  Moore R;  Nolan D;  Orrell C;  Perez C;  Phanuphak P;  Rockstroh J;  Rowling D;  Supparatpinyo K;  Smith D;  Villanueva JA;  Vlahakis E;  Kelleher T;  Cunningham P;  Merlin K;  Yeung J;  Shaik A;  Fsadni B;  Carrera A;  Lograsso M;  Gulick R;  Dunn D;  Dolan M;  Emery S;  Kelleher A, 2015, 'Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study', Lancet Infectious Diseases, 15,  pp. 793 - 802, http://dx.doi.org/10.1016/S1473-3099(15)70060-5
Pinkevych M;  Cromer D;  Tolstrup M;  Grimm AJ;  Cooper DA;  Lewin SR;  Søgaard OS;  Rasmussen TA;  Kent SJ;  Kelleher AD;  Davenport MP, 2015, 'HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission', Plos Pathogens, 11,  pp. e1005000, http://dx.doi.org/10.1371/journal.ppat.1005000
Hey-Cunningham WJ;  Murray JM;  Natarajan V;  Amin J;  Moore CL;  Emery S;  Cooper DA;  Zaunders J;  Kelleher AD;  Koelsch KK;  PINT study team ;  Danta M, 2015, 'Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels.', AIDS, 29,  pp. 911 - 919, http://dx.doi.org/10.1097/QAD.0000000000000625
Suan D;  Nguyen A;  Moran I;  Bourne K;  Hermes JR;  Arshi M;  Hampton HR;  Tomura M;  Miwa Y;  Kelleher AD;  Kaplan W;  Deenick EK;  Tangye SG;  Brink R;  Chtanova T;  Phan TG, 2015, 'T Follicular Helper Cells Have Distinct Modes of Migration and Molecular Signatures in Naive and Memory Immune Responses', Immunity, 42,  pp. 704 - 718, http://dx.doi.org/10.1016/j.immuni.2015.03.002
Winston A;  Amin J;  Clarke A;  Else L;  Amara A;  Owen A;  Barber T;  Jessen H;  Avinghsanon A;  Chetchotisakd P;  Khoo S;  Cooper DA;  Emery S;  Puls R;  Puls R;  Carey D;  Cunningham P;  Kelleher A, 2015, 'Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: A randomized controlled trial', Clinical Infectious Diseases, 60,  pp. 1026 - 1032, http://dx.doi.org/10.1093/cid/ciu976
Madhavi V;  Ana-Sosa-Batiz FE;  Jegaskanda S;  Center RJ;  Winnall WR;  Parsons MS;  Ananworanich J;  Cooper DA;  Kelleher AD;  Hsu D;  Pett S;  Stratov I;  Kramski M;  Kent SJ, 2015, 'Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy', Journal of Infectious Diseases, 211,  pp. 529 - 538, http://dx.doi.org/10.1093/infdis/jiu486
Back to profile page